The World Health Organisation (WHO) Digital Health Technical Advisory Group has agreed an action plan to focus its activities and priorities on advancing the digital health ecosystem whilst safeguarding the misuse of people’s data and protecting their health. Read more “Addressing the world’s most pressing health challenges”
“This is an important step towards relieving the burden of this deadly disease” said the European Medicines Agency’s (EMA) Executive Director. Read more “CHMP recommends granting a conditional marketing authorisation for world’s first Ebola vaccine”
House speaker Nancy Pelosi has unveiled a plan to lower sky-high prescription drug prices in the United States (US). Read more “How would an international price index (IPI) work to lower drug prices in the US?”
From their meeting in September, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has published the highlights. Read more “Highlights from the September CHMP meeting 2019”
At the Medicines and Healthcare products Regulatory Agency (MHRA), an Expert Working Group (EWG) of the United Kingdom’s (UK’s) Commission on Human Medicines (CHM) met to begin reviewing the benefits and risks of opioid medicines, which includes dependence and addiction. Read more “Opioid Expert Working Group meets at MHRA”
Amy Whyte and Kim Wharton wrote an article for the May edition of Regulatory Rapporteur titled ‘A Guide to Legal Status Switches in Europe’.